What was Genex Pharmaceutical’s price range in the past 12 months?
Genex Pharmaceutical lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.
What is Genex Pharmaceutical’s market cap?
Genex Pharmaceutical’s market cap is $3,569.
When is Genex Pharmaceutical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Genex Pharmaceutical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Genex Pharmaceutical pay dividends?
Genex Pharmaceutical does not currently pay dividends.
What is Genex Pharmaceutical’s EPS estimate?
Genex Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genex Pharmaceutical have?
Genex Pharmaceutical has 17,846,000 shares outstanding.
Which hedge fund is a major shareholder of Genex Pharmaceutical?
Currently, no hedge funds are holding shares in GENX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genex Pharmaceutical
Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.